Nelli Erwin
Nelli Erwin is the head of protein stability for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Articles
Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Can Araman;Moritz Beck-Broichsitter;Nelli Erwin ;Supriyadi Hafiz ;Adela Kasselkus ;Thomas Kipping ;David Luedeker ;Aditi Mehta ;Lena Mueller;Sara S. Nogueira;Tobias Rosenkranz;Eleni Samaridou;Johanna Simon
October 7th 2022Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 25th 2024 | Updated: December 24th 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: December 20th 2024 | Updated: December 24th 2024
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Published: February 23rd 2024 | Updated: December 24th 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 24th 2024
FDA Creates CDER Center for Real-World Evidence Innovation
